| pubmed-article:9751352 | pubmed:abstractText | We delineate predictive factors of pulmonary morbidity in patients who receive combination chemotherapy with bleomycin and undergo surgical resection of residual disease, and establish updated guidelines for perioperative management. | lld:pubmed |
